SVB Securities analyst Roanna Ruiz initiated coverage of Cytokinetics with an Outperform rating and $58 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CYTK: